ProLife Medica Sp. z O.O. ETG Poniatowa
- Address
- Ul. Fabryczna 18, 24-320 Poniatowa, Poland
ProLife Medica Sp. z O.O. ETG Poniatowa - Cardiovascular Risk Management Research
ProLife Medica Sp. z O.O. ETG Poniatowa is a clinical research facility specializing in cardiovascular disease prevention and lipid disorder management. The center focuses on evaluating innovative therapeutic approaches for patients at elevated cardiovascular risk, with particular expertise in studying hyperlipidaemia treatments and cholesterol-lowering interventions.
- High-intensity statin therapy and combination lipid-lowering treatments
- LDL-cholesterol reduction strategies in high and very high-risk cardiovascular patients
- Single-pill combination therapies for enhanced treatment compliance and efficacy
The facility conducts comprehensive efficacy and safety assessments of advanced pharmacological interventions, including rosuvastatin and rosuvastatin/ezetimibe combination therapy. Their research emphasizes achieving aggressive LDL-C treatment goals in accordance with contemporary cardiovascular risk stratification guidelines, contributing valuable clinical evidence for optimizing lipid management in patients requiring intensive cardiovascular disease prevention.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 11 therapeutic areas and 15 of 47 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 47 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 7 by active trials.
- 1Eli Lilly & Co.1active
lock +6 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Janssen Cilag International7trials
lock +6 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in ProLife Medica Sp. z O.O. ETG Poniatowa
lock Showing 1 of 41 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2a, Randomized, Placebo-controlled, Double-blind Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of AGMB-129 in Patients with Fibrostenotic Crohn’s Disease | Agomab Spain S.L.U. | Phase II | Not Recruiting | Nov 2023 | Jun 2026 |
IMP list
lock Showing 1 of 47 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Guselkumab | 6 | Unknown | 2018-07-26 | 2024-11-12 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.